Susquehanna International Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $185M | Sell |
390,500
-4,900
| -1% | -$2.47M | 0.02% | 552 |
|
|
2025
Q4 | $185M | Sell |
395,400
-136,400
| -26% | -$63.3M | 0.02% | 565 |
|
|
2025
Q3 | $227M | Buy |
531,800
+94,000
| +21% | +$36.4M | 0.03% | 490 |
|
|
2025
Q2 | $168M | Sell |
437,800
-118,300
| -21% | -$42.6M | 0.02% | 516 |
|
|
2025
Q1 | $192M | Buy |
556,100
+85,500
| +18% | +$27.5M | 0.03% | 405 |
|
|
2024
Q4 | $141M | Buy |
470,600
+260,800
| +124% | +$91.1M | 0.02% | 561 |
|
|
2024
Q3 | $85.3M | Sell |
209,800
-69,700
| -25% | -$25.5M | 0.01% | 733 |
|
|
2024
Q2 | $89.8M | Sell |
279,500
-76,400
| -21% | -$24.8M | 0.02% | 652 |
|
|
2024
Q1 | $119M | Buy |
355,900
+14,900
| +4% | +$4.55M | 0.02% | 585 |
|
|
2023
Q4 | $92.3M | Buy |
341,000
+30,700
| +10% | +$7.59M | 0.02% | 711 |
|
|
2023
Q3 | $76.3M | Buy |
310,300
+1,800
| +0.6% | +$493K | 0.02% | 757 |
|
|
2023
Q2 | $93.6M | Buy |
308,500
+45,900
| +17% | +$12.8M | 0.02% | 645 |
|
|
2023
Q1 | $69.2M | Buy |
262,600
+19,300
| +8% | +$4.9M | 0.01% | 769 |
|
|
2022
Q4 | $58.4M | Buy |
243,300
+12,700
| +6% | +$2.84M | 0.01% | 805 |
|
|
2022
Q3 | $42.4M | Buy |
230,600
+20,300
| +10% | +$4.04M | 0.01% | 899 |
|
|
2022
Q2 | $35.3M | Sell |
210,300
-21,000
| -9% | -$4.51M | 0.01% | 1043 |
|
|
2022
Q1 | $58M | Sell |
231,300
-13,500
| -6% | -$3.39M | 0.01% | 924 |
|
|
2021
Q4 | $63.2M | Sell |
244,800
-33,900
| -12% | -$8.3M | 0.01% | 955 |
|
|
2021
Q3 | $70.3M | Sell |
278,700
-165,800
| -37% | -$40.5M | 0.01% | 959 |
|
|
2021
Q2 | $91.9M | Sell |
444,500
-220,100
| -33% | -$44.9M | 0.01% | 831 |
|
|
2021
Q1 | $125M | Buy |
664,600
+37,500
| +6% | +$6.61M | 0.02% | 629 |
|
|
2020
Q4 | $103M | Sell |
627,100
-173,800
| -22% | -$25.4M | 0.02% | 646 |
|
|
2020
Q3 | $99.9M | Buy |
800,900
+177,200
| +28% | +$21.9M | 0.02% | 566 |
|
|
2020
Q2 | $60.5M | Buy |
623,700
+113,800
| +22% | +$11.8M | 0.01% | 725 |
|
|
2020
Q1 | $45.8M | Buy |
509,900
+94,200
| +23% | +$12.2M | 0.01% | 692 |
|
|
2019
Q4 | $61.4M | Buy |
415,700
+87,400
| +27% | +$11.7M | 0.02% | 703 |
|
|
2019
Q3 | $39.5M | Sell |
328,300
-11,000
| -3% | -$1.42M | 0.01% | 872 |
|
|
2019
Q2 | $45.9M | Buy |
339,300
+15,400
| +5% | +$1.95M | 0.02% | 740 |
|
|
2019
Q1 | $42.2M | Sell |
323,900
-72,300
| -18% | -$9.71M | 0.02% | 719 |
|
|
2018
Q4 | $49.3M | Sell |
396,200
-68,700
| -15% | -$9.22M | 0.02% | 618 |
|
|
2018
Q3 | $64.7M | Buy |
464,900
+47,200
| +11% | +$5.88M | 0.02% | 580 |
|
|
2018
Q2 | $43.1M | Buy |
417,700
+86,800
| +26% | +$8.78M | 0.01% | 766 |
|
|
2018
Q1 | $32.1M | Sell |
330,900
-517,200
| -61% | -$50.2M | 0.01% | 897 |
|
|
2017
Q4 | $74.5M | Buy |
848,100
+133,400
| +19% | +$10.7M | 0.03% | 526 |
|
|
2017
Q3 | $56.9M | Sell |
714,700
-570,900
| -44% | -$45.9M | 0.02% | 581 |
|
|
2017
Q2 | $112M | Sell |
1,285,600
-366,700
| -22% | -$31M | 0.05% | 319 |
|
|
2017
Q1 | $147M | Buy |
1,652,300
+554,500
| +51% | +$46.2M | 0.07% | 231 |
|
|
2016
Q4 | $81.3M | Buy |
1,097,800
+296,900
| +37% | +$22.2M | 0.04% | 390 |
|
|
2016
Q3 | $60.6M | Sell |
800,900
-47,800
| -6% | -$3.66M | 0.03% | 476 |
|
|
2016
Q2 | $65.4M | Sell |
848,700
-188,100
| -18% | -$14.8M | 0.04% | 424 |
|
|
2016
Q1 | $80.9M | Buy |
1,036,800
+224,700
| +28% | +$15.7M | 0.04% | 375 |
|
|
2015
Q4 | $54.9M | Buy |
812,100
+181,700
| +29% | +$12.7M | 0.03% | 561 |
|
|
2015
Q3 | $48.8M | Sell |
630,400
-2,156,300
| -77% | -$191M | 0.02% | 640 |
|
|
2015
Q2 | $253M | Buy |
2,786,700
+2,231,200
| +402% | +$179M | 0.11% | 151 |
|
|
2015
Q1 | $41.8M | Sell |
555,500
-896,300
| -62% | -$64.4M | 0.02% | 729 |
|
|
2014
Q4 | $107M | Buy |
1,451,800
+746,700
| +106% | +$52.5M | 0.04% | 391 |
|
|
2014
Q3 | $49.7M | Buy |
705,100
+34,300
| +5% | +$2.27M | 0.02% | 752 |
|
|
2014
Q2 | $37.8M | Sell |
670,800
-87,000
| -11% | -$4.59M | 0.02% | 883 |
|
|
2014
Q1 | $39.8M | Buy |
757,800
+233,500
| +45% | +$11.6M | 0.02% | 760 |
|
|
2013
Q4 | $25M | Sell |
524,300
-44,300
| -8% | -$2.05M | 0.01% | 1145 |
|
|
2013
Q3 | $24.3M | Buy |
568,600
+112,400
| +25% | +$4.39M | 0.01% | 1071 |
|
|
2013
Q2 | $16.5M | Buy |
+456,200
| New | +$17.6M | 0.01% | 1292 |
|
Other funds holding HCA
VCM
VPM
Susquehanna International Group's HCA Position: Q1 2026 in Review
Susquehanna International Group reduced its HCA Healthcare (HCA) stake by 70% in Q1 2026, selling an estimated $22.9M and leaving 19,531 shares worth $9.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3231.
Susquehanna International Group first reported a position in HCA in Q2 2013 and has held it in 45 quarters since. The position peaked at $51.8M in Q3 2024. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Susquehanna International Group held 19,531 shares of HCA Healthcare worth $9.24M as of Q1 2026.
- Susquehanna International Group sold 45,464 HCA Healthcare shares in Q1 2026, an estimated $22.9M.
- HCA Healthcare made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3231 holding.
- Susquehanna International Group first reported a position in HCA Healthcare in Q2 2013 and has held it in 45 quarters since.
- Susquehanna International Group's HCA Healthcare position peaked at $51.8M in Q3 2024.
- 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.